EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Long-term follow-up of cystic fibrosis patients in the Pleven region over a 28-year period

Nadia I Kolarova, Evgeni V Mekov iD, Nikolay A Yanev iD, Vania N Nedkova

Folia Medica · 2025

DOI: 10.3897/folmed.67.e150928 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Folia Medica, 2025. Verfasst von Nadia I Kolarova und 3 weiteren Autor:innen. Beteiligte Einrichtung: Medical University of Pleven, Pleven, Bulgaria. Hauptthemen laut MEDLINE: Cystic Fibrosis. Die Arbeit nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Cystic fibrosis is a multi-organ genetic disorder with over 1,300 known mutations in the CFTR gene. The diversity of genetic variations leads to a wide range of clinical manifestations and disease severity.

Aim

A retrospective analysis of genetic variants, their associated clinical manifestations at diagnosis, disease progression, and mortality in cystic fibrosis patients in the Pleven region over a 28-year period. Materials and methods : We analyzed 77 patients aged 1 to 32 years with cystic fibrosis, diagnosed and treated at the Pediatric Clinic in Pleven between 1989 and 2017. Diagnosis was based on clinical symptoms, sweat chloride testing, and DNA analysis. Statistical analyses were performed using descriptive statistics.

Results

DNA analysis revealed that 71% of patients were heterozygous for delF508, 20% were homozygous for delF508, and 9% had other mutations. 72.6% of the children were diagnosed before the age of 1 based on bronchopulmonary symptoms and exocrine insufficiency; 27.4% were diagnosed later, despite early respiratory and gastrointestinal symptoms. Follow-up showed mixed pulmonary and gastrointestinal manifestations in 46.5% of patients, 25.9% had only pulmonary symptoms, 15.4% had malabsorption syndrome with steatorrhea, 9.5% had meconium ileus, 8.2% had an edematous-anemic form, and 4% had hepatobiliary involvement. 44.1% of patients died within the first year of life, 7.8% between 1-4 years, and 3.9% between 4-18 years. The analysis shows that the most common mutation in the studied cohort is heterozygosity for delF508, with bronchopulmonary symptoms being the predominant clinical manifestation at diagnosis and during follow-up. Mortality was highest in patients under 1 year of age.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cystic FibrosisHumansMaleCystic Fibrosis Transmembrane Conductance RegulatorFollow-Up StudiesFemaleAdultMutationAdolescentChildYoung Adult

Stichwörter der Autor:innen

cystic fibrosis follow-up mortality mutation

Substanzen

Cystic Fibrosis Transmembrane Conductance RegulatorCFTR protein, human

Autor:innen und Institutionen

  • Medical University of Pleven, Pleven, Bulgaria.
  • Medical University of Sofia, Sofia, Bulgaria.

ORCID-Profile: Evgeni V Mekov, Nikolay A Yanev

Zitieren

APA

Kolarova, N. I., Mekov, E. V., Yanev, N. A., & Nedkova, V. N. (2025). Long-term follow-up of cystic fibrosis patients in the Pleven region over a 28-year period. Folia Medica. https://doi.org/10.3897/folmed.67.e150928

Vancouver

Kolarova NI, Mekov EV, Yanev NA, Nedkova VN. Long-term follow-up of cystic fibrosis patients in the Pleven region over a 28-year period. Folia Medica. 2025. doi:10.3897/folmed.67.e150928

BibTeX
@article{Kolarova2025,
  author = {Kolarova, Nadia I and Mekov, Evgeni V and Yanev, Nikolay A and Nedkova, Vania N},
  title = {Long-term follow-up of cystic fibrosis patients in the Pleven region over a 28-year period},
  journal = {Folia Medica},
  year = {2025},
  doi = {10.3897/folmed.67.e150928}
}
Kostenlos starten →